Texas House of Representatives · 90th Legislature, Regular Session
Official title: Relating to health benefit plan coverage for certain obesity medications.
Members who authored, joint-authored, or co-sponsored this bill.
SourceLegiScan (CC BY 4.0)90R
HB 537 adds Subchapter R to Chapter 1369 of the Insurance Code. It says a health benefit plan that provides prescription drug benefits must cover a prescription drug that is a glucagon-like peptide-1 receptor agonist (a type of medication) to treat obesity. The requirement applies to plans issued by insurance companies, health maintenance organizations, group hospital service corporations, and several other listed types of carriers. The bill also applies it, notwithstanding any other law, to the basic coverage plan under Chapter 1551, the basic plan under Chapter 1575, the primary care coverage plan under Chapter 1579, and the state Medicaid program, including Medicaid managed care under Chapter 540, Government Code. If a state agency decides it needs a waiver or authorization from a federal agency before carrying out any part of the Act, it shall request it and may delay that part until it is granted. The coverage requirement applies only to plans delivered, issued for delivery, or renewed on or after January 1, 2028, and the Act takes effect September 1, 2027. The bill does not state what the requirement would cost; the fiscal note would cover that.
Read the full text below for the definitive meaning.
Each version links to the authoritative document on capitol.texas.gov.
90R690 SCF-D By: Bucy H.B. No. 537 A BILL TO BE ENTITLED AN ACT relating to health benefit plan coverage for certain obesity medications. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Chapter 1369, Insurance Code, is amended by adding Subchapter R to read as follows: SUBCHAPTER R. COVERAGE FOR CERTAIN OBESITY MEDICATIONS
Sec. 1369.781. APPLICABILITY OF SUBCHAPTER. (a) This subchapter applies only to a health benefit plan that provides benefits for medical or surgical expenses incurred as a result of a health condition, accident, or sickness, including an individual, group, blanket, or franchise insurance policy or insurance agreement, a group hospital service contract, or an individual or group evidence of coverage or similar coverage document that is issued by: (1) an insurance company; (2) a group hospital service corporation operating under Chapter 842; (3) a health maintenance organization operating under Chapter 843; (4) an approved nonprofit health corporation that holds a certificate of authority under Chapter 844; (5) a multiple employer welfare arrangement that holds a certificate of authority under Chapter 846; (6) a stipulated premium company operating under Chapter 884; (7) a fraternal benefit society operating under Chapter 885; (8) a Lloyd's plan operating under Chapter 941; or (9) an exchange operating under Chapter 942. (b) Notwithstanding any other law, this subchapter applies to: (1) a basic coverage plan under Chapter 1551; (2) a basic plan under Chapter 1575; (3) a primary care coverage plan under Chapter 1579; and (4) the state Medicaid program, including the Medicaid managed care program operated under Chapter 540, Government Code. Sec. 1369.782. COVERAGE REQUIRED FOR CERTAIN OBESITY MEDICATIONS. A health benefit plan that provides prescription drug benefits must provide coverage for a prescription drug that is a glucagon-like peptide-1 receptor agonist to treat obesity. SECTION 2. If before implementing any provision of this Act a state agency determines that a waiver or authorization from a federal agency is necessary for implementation of that provision, the agency affected by the provision shall request the waiver or authorization and may delay implementing that provision until the waiver or authorization is granted. SECTION 3. Subchapter R, Chapter 1369, Insurance Code, as added by this Act, applies only to a health benefit plan delivered, issued for delivery, or renewed on or after January 1, 2028. SECTION 4. This Act takes effect September 1, 2027.
Statewide figures for the subjects tagged on this bill, to explore on the Data map. They describe Texas — not this bill or its effects.
SourceU.S. Census Bureau (ACS) & CDC PLACESstatewide Data layer
Each subject links to other 90R bills tagged the same way.
SourceTexas Legislative Council (capitol.texas.gov)90R
No recorded roll-call votes on this bill.
SourceLegiScan (CC BY 4.0)90R
No fiscal notes or analyses recorded for this bill.
SourceLegiScan (CC BY 4.0)official fiscal notes & analyses (TLC)
Perch never collects comments itself — it points you to the Legislature's own hearing schedule and official public-comment channels (ADR-0007).
Official hearings & comment (capitol.texas.gov) →SourceTexas Legislative Council (capitol.texas.gov)official bill text (capitol.texas.gov)
SourceLegiScan (CC BY 4.0)subject tags